News

Nigeria: R21 Malaria Vaccine – Clinical Trials ‘Ll Begin in 6 Weeks – NAFDAC

[Vanguard] The Director General of the National Agency For Food and Drug Administration and Control, NAFDAC, Professor Mojisola Adeyeye, said yesterday that the approval process for the R21/Matrix-M malaria vaccine requires more clinical trials before its full use.

Related posts

Leave a Comment